306
S. Xue et al. / Carbohydrate Research 340 (2005) 303–307
1.1.1.1. C-4-O-Acetyl-[6-O-(tert-butyldimethylsilyl)-
2,3-dideoxy-a-D-erythro-hex-2-enopyranosyl]methane (4a).
n-BuLi (240 lL, 0.6 mmol, 2.0 equiv). The mixture was
stirred at room temperature for 30 min, then a solution
of ZnCl2 (82 mg, 0.6 mmol, 2.0 equiv) in 1.0 mL of
Et2O was added via syringe at 0 ꢁC. Transfer of the ZnCl2
was made quantitative with an additional 0.5 mL of
Et2O. After the white suspension was stirred at room
temperature for 1 h, a solution of 3,4,6-tri-O-acetyl-D-
glucal (81.6 mg, 0.3 mmol) in 1.5 mL of Et2O was added
at À78 ꢁC, followed by addition of BF3ÆEt2O (159 lL,
0.6 mmol, 2.0 equiv). Then the reaction flask was moved
from the cold bath and stirred for 1–2 h at room temper-
ature. The reaction was quenched by addition of 2.5 mL
of satd aq NH4Cl and extracted with Et2O (3 · 10 mL).
The combined organic extracts was washed with brine,
dried over MgSO4 and concentrated under reduced pres-
sure. The desired product was isolated by silica gel chro-
matography with 15:1 petroleum ether–EtOAc.
IR (neat, cmÀ1) 2956, 1743, 1466, 1237, 1192, 1049, 970,
1
839, 779; H NMR (CDCl3, 300 MHz) (a-anomer): d
5.87 (td, J 1.4, 10.1 Hz, 1H), 5.78 (td, J 2.2, 10.1 Hz,
1H), 5.11 (m, 1H), 4.38–4.35 (m, 1H), 3.82–3.71 (m,
3H), 2.08 (s, 3H), 1.29 (d, J 6.8 Hz, 3H), 0.90 (s, 9H),
0.08 (s, 3H), 0.07 (s, 3H); 13C NMR (CDCl3, 75 MHz)
(a-anomer): d 170.7, 135.2, 122.9, 73.2, 67.6, 65.5, 62.9,
1
29.9, 26.0, 21.4, 19.6, À5.2, À5.3; H NMR (CDCl3,
300 MHz) (b-anomer): d 5.78 (m, 1 H), 5.71 (m, 1H),
5.21 (m, 1H), 4.23 (m, 1H), 3.82–3.71 (m, 2H), 3.57 (m,
1H), 2.06 (s, 3H), 1.23 (d, J 6.7 Hz, 3H), 0.90 (s, 9H),
0.08 (s, 3H), 0.07 (s, 3H); HRCIMS: Calcd for
C15H29O4Si, m/z 301.1835 [MH]+. Found: m/z 301.1840.
1.1.1.2. C-4-O-Acetyl-[6-O-(tert-butyldimethylsilyl)-
2,3-dideoxy-a-D-erythro-hex-2-enopyranosyl]benzene (4b).
IR (neat, cmÀ1) 2931, 1740, 1494, 1095, 973, 838, 779,
700; 1H NMR (CDCl3, 300 MHz) for a-anomer: d
7.44–7.33 (m, 5H), 6.16 (br d, J 10.3 Hz, 1H), 5.99 (br
d, J 10.3 Hz, 1H), 5.29 (m, 2H), 3.74 (m, 3H), 2.08 (s,
3H), 0.87 (s, 9H), 0.07 (s, 3H), 0.04 (s, 3H); 13C NMR
(CDCl3, 75 MHz): d 170.6, 139.5, 131.9, 128.5, 128.0,
127.8, 124.9, 73.5, 72.4, 65.5, 63.1, 25.9, 21.3, 18.4,
À5.4, À5.3; HRCIMS: Calcd for C20H31O4Si, m/z
363.1992 [MH]+. Found: m/z 363.1986.
1.1.2.1. 1-C-[4,6-Di-O-acetyl-2,3-dideoxy-a-D-erythro-
hex-2-enopyranosyl]-4-bromobenzene (2e). IR (neat,
cmÀ1) 2953, 1740, 1370, 1233, 1047, 801; 1H NMR
(CDCl3, 300 MHz): d 7.45 (d, J 8.1 Hz, 2H), 7.23 (d, J
8.1 Hz, 2H), 6.08 (d, J 9.8 Hz, 1H), 5.94 (d, J 9.8 Hz,
1H), 5.22–5.11 (m, 2H), 4.20 (dd, J 6.0, 11.7 Hz, 1H),
4.03 (dd, J 2.4, 11.7 Hz, 1H), 3.76–3.75 (m, 1H), 2.05
(s, 3H), 2.03 (s, 3H); 13C NMR (CDCl3, 75 MHz): d
170.7, 170.3, 130.0, 131.7, 130.9, 129.6, 125.4, 122.3,
73.0, 69.5, 64.9, 62.8, 21.0, 20.8. HRCIMS: Calcd for
C16H18BrO5, m/z 369.0337 [MH]+. Found: m/z
369.0338.
1.1.1.3. trans-5,6-Dihydro-2-ethyl-6-phenethyl-2-phen-
yl-H-pyran (4c). IR (neat, cmÀ1) 3030, 2963, 1602,
1454, 1261, 1023, 801, 699; 1H NMR (CDCl3,
300 MHz): d 7.27–7.15 (m, 5H), 5.75–5.70 (m, 2H),
4.05 (m, 1H), 3.65 (m, 1H), 2.84 (m, 1H), 2.66 (m,
1H), 1.96–1.87 (m, 3H), 1.73 (m, 1H), 1.58 (m, 1H),
1.48 (m, 1H), 1.00 (t, J 7.3 Hz, 3H); 13C NMR
(CDCl3, 75 MHz): d 142.5, 129.9, 128.6, 128.4, 125.8,
123.9, 74.1, 67.1, 37.3, 32.2, 30.1, 27.3, 10.7; HREIMS:
Calcd for C15H20O, m/z 216.1514 [M]+. Found: m/z
216.1518.
Acknowledgements
We thank the National Natural Science Foundation of
China (20202009) for financial support.
Supplementarydata
Supplementary data associated with this article can be
1.1.1.4. trans-5,6-Dihydro-2-methyl-6-phenethyl-2H-
pyran (4d). IR (neat, cmÀ1) 3029, 2926, 1604, 1495,
1454, 1365, 1240, 1051, 952, 750, 700; 1H NMR (CDCl3,
300 MHz): d 7.22–7.09 (m, 5H), 5.69–5.66 (m, 2H),
4.30 (m, 1H), 3.60 (m, 1H), 2.72 (m, 1H), 2.61 (m,
1H), 1.90–1.66 (m, 4H), 1.17 (d, J 6.8 Hz, 3H); 13C
NMR (CDCl3, 75 MHz): d 142.3, 131.0, 128.6, 128.3,
125.8, 123.5, 68.5, 66.6, 37.0, 31.9, 30.7, 20.1; HREIMS:
Calcd for C14H18O, m/z 203.1436 [M]+. Found: m/z
203.1439.
References
1. (a) Faul, M. M.; Huff, B. E. Chem. Rev. 2000, 100, 2407–
2473; (b) Kirshning, A.; Chen, G. W.; Drager, G.;
Schuberth, I.; Tietze, L. Biorg. Med. Chem. 2000, 8,
2347–2354; (c) Fraser, R. B. Acc. Chem. Res. 1985, 18,
347–354.
2. (a) Saibal, K. D.; Reddy, K. A.; Abbineni, C.; Roy, J.;
Rao, K. V. L. N.; Sachwani, R. H.; Iqbal, J. Tetrahedron
Lett. 2003, 44, 4507–4509; (b) Yadav, J. S.; Subba, B. V.;
Chand, P. Tetrahedron Lett. 2001, 42, 4045–4059; (c)
Toshima, K.; Matsuo, G.; Ishizuka, T.; Ushiki, Y.;
Nakata, M.; Matsumura, S. J. Org. Chem. 1998, 63,
1.1.2. Standard procedure for preparation of aryl C-gly-
cosides with ArZnCl.
To a solution of aryl halide (0.6 mmol, 2.0 equiv) in Et2O
(1.5 mL) at 0 ꢁC was added dropwise a solution of 2.5 M